Company Filing History:
Years Active: 1984
Title: Anneliese D Recklies: Innovations in Tumor Enzyme Detection
Introduction:
Anneliese D Recklies, a talented scientist and inventor, hails from Point Claire, CA. With a remarkable career dedicated to groundbreaking research, Recklies has made significant contributions to the field of tumor enzyme detection. Working at Shriners Hospitals for Crippled Children, Recklies has exemplified exceptional expertise and innovation in her field.
Latest Patents:
Recklies has been granted a notable patent for her invention titled "Tumor Enzyme Detection." This groundbreaking patent provides a method for preparing a monospecific antibody to detect cathepsin B proteinase, an enzyme associated with tumor development. The innovative process involves homogenizing purified cathepsin B proteinase, dialyzing to remove ampholines, and intramuscularly injecting a proteinase emulsion into an animal. The patent further outlines the steps for extracting monospecific antiserum from the animal's blood, subsequently enabling tumor enzyme detection.
Career Highlights:
Through her career, Recklies has dedicated her efforts to advancing medical discoveries related to tumor enzymes. Her work at Shriners Hospitals for Crippled Children has been instrumental in improving diagnostic techniques and enhancing our understanding of tumor biology. Recklies' commitment to research and innovation has yielded numerous breakthroughs, including her patented method for tumor enzyme detection.
Collaborations:
Throughout her career, Recklies has had the privilege of collaborating with esteemed colleagues who share her passion for medical advancements. Notably, she has worked closely with A. Robin Poole and John S. Mort, two renowned researchers in the field. Their collective efforts have contributed to the development of novel approaches in tumor enzyme detection and have paved the way for future breakthroughs in this critical area.
Conclusion:
Anneliese D Recklies is a remarkable scientist and inventor, whose tireless dedication to tumor enzyme detection has garnered recognition and praise. Her groundbreaking patent demonstrates her innovative thinking and commitment to advancing cutting-edge diagnostic techniques. Recklies' collaborations with respected researchers have further solidified her position as a leading figure in this field. As we await her future contributions, it is evident that Anneliese D Recklies continues to push boundaries and inspire the scientific community with her exceptional work in innovations and patents.